Form 8-K TREACE MEDICAL CONCEPTS, For: Sep 27
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
|
|
|
|
|
|
|
(Address of Principal Executive Offices, including Zip Code) |
|
Registrant’s Telephone Number, Including Area Code: ( |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On September 27, 2022, Treace Medical Concepts, Inc. (the “Company”) announced that the Board of Directors of the Company (the “Board”) has, based on the recommendation of the Board’s Nominating, Compliance and Governance Committee, appointed Lance A. Berry and Jane E. Kiernan to the Company’s Board effective October 1, 2022. Ms. Kiernan will serve on the Compensation Committee, and Mr. Berry will serve on the Audit Committee. Mr. Berry will serve as a Class II director whose term will expire at the Company’s 2023 Annual Meeting of Stockholders, and Ms. Kiernan will serve as a Class III director whose term will expire at the Company’s 2024 Annual Meeting of Stockholders.
Mr. Berry and Ms. Kiernan will be eligible to participate in the Company’s non-employee director compensation program, which compensation program was described in the Company’s proxy statement for its 2022 annual meeting of stockholders filed with the Securities and Exchange Commission (the “SEC”) on April 4, 2022. Each of Mr. Berry and Ms. Kiernan have also entered into the Company’s standard form of indemnification agreement, the form of which is filed as Exhibit 10.1 to the Company’s Registration Statement on Form S-1/A filed with the SEC on April 19, 2021.
The Board has determined that each of Mr. Berry and Ms. Kiernan qualify as independent directors under the rules and regulations of the Nasdaq Global Select Market.
There is no arrangement or understanding between Mr. Berry or Ms. Kiernan and any other person, pursuant to which Mr. Berry or Ms. Kiernan were selected as a director on the Board, nor is Mr. Berry or Ms. Kiernan a member of the family of any executive officer of the Company or of any other director on the Board. There have been no transactions, proposed or otherwise, in which Mr. Berry or Ms. Kiernan participated or will participate that would be required to be disclosed herein pursuant to Item 404(a) of Regulation S-K.
A copy of the press release issued by the Company announcing the appointment of Mr. Berry and Ms. Kiernan to the Board is attached hereto as Exhibit 99.1 and incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
Exhibit No. |
Description |
Exhibit 99.1 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
Treace Medical Concepts, Inc. |
|
|
|
|
Date: |
September 27, 2022 |
By: |
/s/ Mark L. Hair |
|
|
|
Chief Financial Officer |
ATTACHMENTS / EXHIBITS
XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: RH, Estee Lauder rise; Tesla falls
- Behavioral Health’s Forge Health Marks Next Phase with Board of Directors Expansion and Advisory Board Creation
- Coalition Insurance Company Now Quoting in All 50 U.S. States and D.C.
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!